ATM kinase modulation for screening and therapies
AssigneesSt. Jude Children's Research Hospital, The Johns Hopkins University
InventorsMichael Kastan, Christine Canman, Seong-Tae Kim, Dae-Sik Lim
Life of this patent
Estimating the term…
Loading patent…
AssigneesSt. Jude Children's Research Hospital, The Johns Hopkins University
InventorsMichael Kastan, Christine Canman, Seong-Tae Kim, Dae-Sik Lim
Estimating the term…
The present invention relates to identification of the consensus sequence phosphorylated by ATM kinase. This, in turn, permitted identification of ATM kinase target proteins, and development of a convenient assay system for ATM kinase phosphorylation using fusion polypeptides as substrates. The assay system is adaptable to screening for ATM modulators, particularly inhibitors. In a specific embodiment, the substrate recognition sequence and mutagenized variants of this sequence were incorporated in a GST fusion protein and assayed for phosphorylation by ATM kinase. This assay system is useful in screening for ATM inhibitors. ATM function assays were validated using an ATM-kinase dead dominant-negative mutant.
A method for screening for a compound that modulates ATM-mediated phosphorylation, comprising detecting whether there is a change in the level of ATM-mediated phosphorylation of a polypeptide, said polypeptide being different from a full-length p53 protein and comprising an ATM substrate recognition sequence B2—X—B2—S—Q—X—X (SEQ ID NO:
Dependencies are inferred from the claim text.